4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-029859
Chief Business Officer sold 75,000 shares at $30.05 ($2,253,885)
- Chief Business Officer acquired 75,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Parrish Jay · Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-14 | Exercise or conversion : show line 1 in the form | +75,000 | $1.49 | $111,375 | 297,222 | D |
| 2020-05-14 | Sale : show line 2 in the form | −75,000 | $30.05 | $2,253,885 | 222,222 | D |
| Open-market sales · 75,000 sh · avg $30.05 · $2,253,885 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-05-14 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −75,000 | 147,221 | D |
Loading xslF345X03/doc4.xml…